WHO Recommends Testing Two New Ebola Vaccines in the DRC
Moscow (ANTARA) – The World Health Organization (WHO) has recommended adding two new Ebola vaccines to clinical trials in the Democratic Republic of the Congo.
“An expert group established by the World Health Organization (WHO) has recommended adding two new Ebola vaccine candidates to the ongoing Tumaini clinical trial in the DRC.
“This recommendation marks the first time that vaccines specifically developed to provide protection against the Bundibugyo virus, which is causing the current outbreak, will be evaluated while an outbreak of the disease is under way,” the WHO said in a statement on Wednesday.
The ChAdOx1 vaccine candidate was developed by the University of Oxford in collaboration with the Serum Institute of India. The mRNA-1469 candidate was developed by Moderna.
According to the latest data, confirmed deaths from Ebola in the DRC have reached 5,103, with 10,467 cases of infection.
Source: jawawa.id (https://jawawa.id/newsitem/who-recommends-testing-two-new-ebola-vaccines-in-the-drc-1793861762)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5833479/who-sarankan-uji-klinis-dua-vaksin-baru-ebola-di-rd-kongo), translated from Indonesian